Esters of succinic acid are potent insulin secretagogues, and have been proposed as novel antidiabetic agents for type 2 diabetes. This study examines the effects of acute and chronic exposure to succinic acid monomethyl ester (SAM) on insulin secretion, glucose metabolism and pancreatic beta cell function using the BRIN-BD11 cell line. SAM stimulated insulin release in a dose-dependent manner at both non-stimulatory (1.1mM) and stimulatory (16.7mM) glucose. The depolarizing actions of arginine also stimulated a significant increase in SAM-induced insulin release but 2-ketoisocaproic acid (KIC) inhibited SAM induced insulin secretion indicating a possible competition between the preferential oxidative metabolism of these two agents. Prolonged (18hour) exposure to SAM revealed decreases in the insulin-secretory responses to glucose, KIC, glyceraldehyde and alanine.
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Furthermore, SAM diminished the effects of nonmetabolized secretagogues arginine and 3-isobutyl-1-methylxanthine (IBMX) . While the ability of BRIN-BD11 cells to oxidise glucose was unaffected by SAM culture, glucose utilization was substantially reduced. Collectively, these data suggest that while SAM may enhance the secretory potential of non-metabolized secretagogues, it may also serve as a preferential metabolic fuel in preference to other important physiological nutrients and compromise pancreatic beta cell function following prolonged exposure.
INTRODUCTION
Succinic acid serves as an important cellular metabolic intermediate of glucose and mannose [11 and may act as a metabolic fuel through its rapid mitochondrial metabolism. [2] However, unlike glucose and other metabolizable nutrient fuels such as the amino acids, [3] [4] [5] succinic acid is not readily internalized into cells. [2, 6] Addition of ester moieties to molecules has long served as an efficient means of internalizing compounds that are not otherwise transported across the plasma membrane. [7] Various esters of a diverse range of nutrients and nutrient metabolites have been demonstrated to exhibit enhanced biological and insulinotropic activity over their parent molecules. [8] [9] [10] [11] [12] [13] [14] [7, [15] [16] [17] [18] Esters of succinic acid, serving as potent insulin secretagogues, have therefore been proposed to be potential novel antidiabetic agents for the treatment of non-insulin-dependent diabetes mellitus. [6, 8] 23 .5% (v/v) H20 was added. [19] After an overnight incubation at 4C, cells were disrupted and acid-ethanol extracts removed and stored at -20C for determination of insulin. [27] Glucose Metabolism Glucose oxidation and utilization were assessed after an 18h culture in the absence or presence of 20mM SAM using methods described previously. [28, 29] Briefly, BRIN (Fig. 1) .
Effects of SAM and Insulinotropic Actions of Nutrients and 3-Isobutyl-l-Methylxanthine As shown in Figure 2 (Fig. 4) . SAM Glucose concentration (mM) normal pancreatic beta cells. [7, [15] [16] [17] [18] 30] In addition to the characteristic glucose-responsiveness of BRIN-BD11 cells, notable insulinsecretory responses were also observed using a range of other important nutrient secretagogues and the phosphodiesterase inhibitor, IBMX. [3] As with glucose, SAM effectively utilized the stimulatory actions of the glycolytic fuel, glyceraldehyde to enhance its insulinotropic activity. Similarly, the depolarizing actions of arginine [21] were also able to stimulate a significant increase in SAM-induced insulin release. While, alanine and IBMX showed no synergistic actions with SAM, in the presence of KIC there was a significant inhibition of insulin release. KIC is a potent initiator of insulin secretion and is rapidly transported into beta cells [31, 321 where it is readily available as a metabolic fuel. [33] [34] [35] The inhibitory effect of KIC on SAM-induced insulin release may reflect some form of competition in the oxidative metabolism of these two agents, which are immediately and completely utilized. Consistent with the view that SAM may interfere with the metabolism of other secretagogues, prior exposure to SAM (during a 40 minute preincubation period) significantly decreased the subsequent responsiveness to KIC and glyceraldehyde. The secretory activity of IBMX was also reduced, and the insulinotropic potential of arginine, which does not serve as a significant fuel for beta cell metabolism [5, 21] was significantly enhanced. Together these data suggest that SAM may, like glucose, enhance the secretory potential of non-metabolizable secretagogues, [21, 36, 37] [7, 15] the present in vitro study suggests that more prolonged exposure may substantially alter insulin-secretory responsiveness. These data merit substantiation by in vivo studies, but similar desensitization of insulin-secretory function has been observed with sulphonylureas both in vivo and in vitro during extended culture. [25, 26, 38, 39] These findings clearly show the need for further research bearing in mind that SAM represents only one of an growing number of insulinotropic nutrient esters [8, which may prove to be better candidates for the future therapy of type 2 diabetes.
